# Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects

> **NCT01415778** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ICI176,334-1
- **DRUG:** Casodex 80 mg tablet

## Key facts

- **NCT ID:** NCT01415778
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01415778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01415778, "Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01415778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*